Use of a pyruvate kinase activator in the treatment of renal fibrosis and other renal diseases

TW202633630APending Publication Date: 2026-08-16AGIOS PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141526
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-28
Filing Date
2025-10-27
Publication Date
2026-08-16

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Provided herein is the use of pyruvate kinase (PK) activators or pharmaceutically acceptable salts or compositions thereof, for treating renal fibrosis and other renal diseases.
Need to check novelty before this filing date? Find Prior Art